The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bredt David since 2025.
This trader's CIK number is 2022087.
At the time of last reporting, Bredt David was the Chief Scientific Officer of Rapport Therapeutics, Inc.. (stock ticker symbol RAPP).
Also see all insider trading activities at Rapport Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RAPP | 0 | $0 | 42,500 | $516,765 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | RAPP | Sale | 8,500 | 15.38 | 130,755 |
| 2025-07-15 | RAPP | Sale | 8,500 | 14.00 | 118,966 |
| 2025-06-16 | RAPP | Sale | 8,500 | 11.00 | 93,525 |
| 2025-04-15 | RAPP | Sale | 8,500 | 9.57 | 81,311 |
| 2025-03-14 | RAPP | Sale | 8,500 | 10.85 | 92,208 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bredt David (Chief Scientific Officer of Rapport Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.